Perez-Sanches, C., et al. Molecular Characterization of the Serum Profile Associated to The Increased Cardiovascular Risk in Rheumatoid Arthritis Patients. Effects of Biological Drugs. Annals of the Rheumatic Diseases 2019;78(S2):SAT0124
Songia, P., et al. direct screening of plasma circulating microRNAs. RNA Biol. 2018 Sep 25. doi: 10:1080/15476286.2018. 1526538. [Epub ahead of print].
Bell, A. et al, Detection of a MicroRNA molecular signature of ultraviolet radiation in the superficial regions of melanocytic nevi on sun-exposed skin. Modern Pathology 2018 Jun 28. doi: 10.1038/s41379-018-0088-5. [Epub ahead of print].
Lopez-Pedrera, C., et al. Circulating mirnas as potential biomarkers of disease and cardiovascular risk in rheumatoid arthritis patients. Annals of the Rheumatic Disease 2018 (77) S2
Schordan, E., et al. Rabiopred, an innovative theranostic tool to assist clinicians select an optimal anti-tnf alpha biological therapy for rheumatoid arthritis patients. Abstract presented at Ann Rheum Disease Conference Proceeding 2018 JUN 18
Petrick, J., et al. Circulating Micrornas in Relation to Esophageal Adenocarcinoma Development and Survival. Abstract presented at American Gastroenterological Association 2018 MAY 1 (154) 6: S1, S-987 DOI:https://doi.org/10.1016/S0016-5085(18)33309-2
Saller, J., et al. An miRNA signature selects patients at risk for Barrett's Esophagus progression to dysplasia and cancer. Abstract presented American Association for Cancer Research Annual Meeting 2018 July 14-18, Chicago, IL. DOI: 10.1158/1538-7445.AM2018-5410
Koptyra, M., et al. Empowering rare disease cohort biomarker discovery via comparative assessments of gene expression analysis platforms for FFPE pediatric brain tumor specimens. Abstract #2081 presented at: American Association for Cancer Research Annual Meeting (AACR) 2018 Apr 14-18; Chicago, IL
Download pdf 6.3MB
View External Link
Geva, S., et al. The Interaction Between Mast Cells and Lung Cancer Cells Through Extracellular Vesicles. Journal of Thoracic Oncology 2017; 12(11):S2272
Satake, E. et al., Circulating miRNAs profile and risk of end-stage renal disease in type 1 diabetes. Abstract presented at: American Society of Nephrology (ASN). 2017 Nov; New Orleans, LA.
Higgins, K., et al. Circulating Pre-treatment miRNAS as Potential Biomarkers to Predict Radiation Toxicity. International Journal of Radiation Oncology. 2017;99(2), Suppl, PE596
Page last updated May 22, 2023